Clinical trial Recruiting at 1 site Interventional Ages 3 to 8

Evaluating a device for screening vision problems in young children

Official title: Evaluation of the Photorefraction Screener Snapsight in Comparison With Cycloplegia Table-top Autorefractor in Ametropia in Pediatric Population Between 3 and 8yo, Multicenter French Study.

Run by Essilor International · NCT06882408 · Data updated 2026-11-12

This study is testing a new device to see if it can effectively find vision problems in children aged 3 to 8, whether they wear glasses or not.

Quick facts

Study typeInterventional
Ages3 Years to 8 Years
SexAll
Enrollment315 (estimated)
SponsorEssilor International
Industry-sponsored
Locations2 sites (Nancy, France and 1 other locations)
StatusRecruiting
StartedApril 2025
Main results expectedDecember 2025
Study endsDecember 2025
Registry record updatedApril 29, 2025
Trial IDNCT06882408 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 3 to 8 years, regardless of whether they wear glasses.

Probably not a fit

Patients with ocular or systemic pathologies affecting vision or those currently using contact lenses may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to assess the performance of a photorefraction device in screening for ametropia in children aged 3 to 8 years. Participants will undergo multiple refractive error measurements, visual acuity tests, and strabismus assessments during a single visit. The study compares the results from the investigational device with those obtained from a gold standard tabletop refractometer to evaluate sensitivity, specificity, and accuracy. The trial includes children who wear glasses or do not, ensuring a comprehensive assessment of the device's effectiveness.

Why it matters

Potential benefit: If successful, this study could lead to improved screening methods for refractive errors in children, facilitating early detection and treatment.

How similar studies have gone: Other studies have shown promise in using photorefraction devices for screening, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged between 3-8 years when included in the study
* All skin phototypes (I to VI according to the Fitzpatrick classification)
* Wearing glasses or not
* Capacity to give valid consent
* Capacity to follow the protocol to obtain reliable measure
* Under French medical insurance

Exclusion Criteria:

* Under myopia control solution that may have an impact on refractive error (such as: atropine, orthokeratology,..)
* Wearing contact lenses
* Ocular or systemic pathology that may have an impact on vision or may interfere with the study measures (except strabismus)
* Under medication that may have an impact on vision or may interfere with study measurements
* Known contraindication to the active substance or to one of the excipients of eye drops (Mydriaticum 0.5%, Skiacol 0.5%)
* Known risk of angle-closure glaucoma
* Participation to another study that may have an impact on vision or may interfere with the study measures

Where it's running

  • Hôpital civil de Strasbourg
    Strasbourg, France, France
    Recruiting
  • Dr Krafft private practice
    Nancy, France, France
    Not yet recruiting

Study contacts

  • Principal investigator: Aranaud Sauer, MD, PhD, FEBO — Hôpital Civil de Strasbourg
  • Study coordinator: Sara Cadoni
  • Email: cadonis@essilor.fr
  • Phone: +33 642665760

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Optimizing light exposure to prevent and control myopia in children

    This study tests if changing classroom lighting to mimic sunlight or using a smartphone app to guide light exposure can help prevent and control myopia in primary school children.

    Recruiting at 5 sites National University of Singapore · Singapore and 4 other locations · NCT06631339

  • Two monthly silicone hydrogel multifocal toric contact lenses in wearers with astigmatism and myopia

    This study tests whether two popular soft multifocal toric contact lenses perform differently in adults who need vision correction for astigmatism and myopia.

    Recruiting CooperVision International Limited (CVIL) · New York, New York and 2 other locations · NCT07829419

  • Seeing clearly in low light after Ray-Tracing guided LASIK

    A trial tests how well WaveLight Plus LASIK works for people with myopia and astigmatism and whether patients are satisfied after the procedure.

    Recruiting Phase 4 Vance Thompson Vision · Sioux Falls, South Dakota · NCT07790185

  • Orthokeratology contact lenses with a 5 mm optic zone diameter

    This study tests Paragon CRT lenses with a 5 mm optic zone in kids and young adults to see how well they fit, how well they vision, and how comfortable they are at night.

    Recruiting at 2 sites CooperVision International Limited (CVIL) · Pleasanton, California and 2 other locations · NCT07751172

  • SMILE in one eye vs Ray tracing-guided LASIK in the fellow eye

    This study tests two laser vision correction methods—SMILE in one eye and ray-tracing guided LASIK in the other eye—to see which provides better vision and quality of life for adults with myopia and astigmatism.

    Recruiting Phase 4 Stanford University · Palo Alto, California · NCT07721714

  • A.M.L. spectacle lenses for children with myopia

    We will try A.M.L. spectacle lenses in 6- to 12-year-old children with myopia to see how quickly they adapt and how comfortable the lenses feel.

    Recruiting Essilor International · Shanghai, Shanghai Municipality · NCT07354945

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.